# Australian Foundation Investment Company Limited (NZX:AFI)

**Exchange:** NZX (XNZE)
**Sector:** Financials
**ISIN:** AU000000AFI5
**LEI:** 254900YODBY7EY7U4G44
**Financial year-end:** June

## Overview

AFT Pharmaceuticals develops, manufactures, and markets pharmaceutical products including pain management, eye care, and consumer healthcare products sold in over 100 countries globally.

## Market

- **Market cap:** NZ$10.23B (most recent close)

## Latest annual results (FY2025)

- **Revenue:** NZ$328.1M
- **Net profit:** NZ$285.0M
- **EPS:** 52.27c
- **Total assets:** NZ$10.58B
- **Total equity:** NZ$8.74B
- **Net margin:** 86.8%
- **Return on equity:** 3.3%
- **Debt-to-equity:** 0.21

All figures sourced from the company's most recent annual report. Monetary values in New Zealand dollars.

## Governance

- **Governance Risk Score (NZXplorer methodology):** 82.76 — Excellent (calculated 2026-06-01T12:33:18.751+00:00)
- **Board size:** 13 directors, 85% independent
- **Chair:** [Craig Drummond](https://nzxplorer.co.nz/people/craig-drummond)

## Latest NZX announcement

- **Notification of buy-back** (2026-05-19, SECISSUE)
- Source: https://www.nzx.com/announcements/472976

## More data

- Company page: https://nzxplorer.co.nz/companies/australian-foundation-investment
- Structured facts (JSON): https://nzxplorer.co.nz/api/v1/companies/AFI/facts.json
- Full detail API: https://nzxplorer.co.nz/api/v1/companies/AFI?include=all
- Company website: http://www.afi.com.au/
- NZX page: https://www.nzx.com/companies/AFI

---

Published by [NZXplorer](https://nzxplorer.co.nz). Canonical: https://nzxplorer.co.nz/companies/australian-foundation-investment. Data licence: CC BY 4.0 with attribution to NZXplorer + NZX as primary disclosure source. Generated 2026-06-03.